Cutaneous Warts
4
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
1
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
MaruhoCLS003
MaruhoCLS003
Combined Therapeuticsliq nitrogen
Human BioSciencesCypep-1
Clinical Trials (4)
Total enrollment: 209 patients across 4 trials
A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.
Start: Jan 2015Est. completion: Aug 201581 patients
Phase 2Completed
First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts
Start: Mar 201412 patients
Phase 1/2Completed
Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts
Start: May 2022Est. completion: Nov 202260 patients
Phase 1Completed
CyPep-1 in Cutaneous Warts
Start: Mar 2019Est. completion: Dec 201956 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.